KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATFurniture, Fixtures and OtherGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Boston Scientific (BSX) Shares Issued (2016 - 2026)

Boston Scientific's Shares Issued history spans 18 years, with the latest figure at $81.0 million for Q1 2026.

  • On a quarterly basis, Shares Issued fell 29.57% to $81.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $248.0 million, a 6.42% decrease, with the full-year FY2025 number at $282.0 million, up 22.61% from a year prior.
  • Shares Issued hit $81.0 million in Q1 2026 for Boston Scientific, up from $20.0 million in the prior quarter.
  • Over the last five years, Shares Issued for BSX hit a ceiling of $115.0 million in Q1 2025 and a floor of $6.0 million in Q2 2022.
  • Historically, Shares Issued has averaged $53.6 million across 5 years, with a median of $52.0 million in 2022.
  • Biggest five-year swings in Shares Issued: tumbled 70.0% in 2022 and later skyrocketed 350.0% in 2023.
  • Tracing BSX's Shares Issued over 5 years: stood at $19.0 million in 2022, then decreased by 10.53% to $17.0 million in 2023, then skyrocketed by 64.71% to $28.0 million in 2024, then fell by 28.57% to $20.0 million in 2025, then soared by 305.0% to $81.0 million in 2026.
  • Business Quant data shows Shares Issued for BSX at $81.0 million in Q1 2026, $20.0 million in Q4 2025, and $115.0 million in Q3 2025.